News Releases
| 2010 | |||
| 01/10/2010 | US EDUCATIONAL SUPPORT SERVICE FOR MS COMMUNITY, MS LIFELINES®, REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS
Geneva, Switzerland |
English French German |
|
| 28/07/2010 | MERCK SERONO: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS
Geneva, Switzerland |
English French German |
|
| 12/07/2010 | MERCK SERONO’S CLADRIBINE TABLETS FOR MS APPROVED IN RUSSIA
Geneva, Switzerland |
English French German |
|
| 29/06/2010 | MERCK SERONO TO AWARD GRANT TO INNOVATIVE RESEARCH PROJECTS IN FERTILITY
Geneva, Switzerland |
English French German |
|
| 28/06/2010 | FINDINGS FROM GLOBAL SURVEY HELP UNDERSTAND FERTILITY TRENDS AND BARRIERS TO SEEKING MEDICAL HELP AGAINST INFERTILITY
Geneva, Switzerland |
English French German |
|
| 25/06/2010 | MERCK SERONO CALLS FOR ENTRIES TO REAL MS - YOUR STORY, A GLOBAL COMPETITION TO RAISE AWARENESS OF MULTIPLE SCLEROSIS Geneva, Switzerland |
English French German |
|
| 17/06/2010 | Data to Be Presented at ENS 2010 Meeting Underscore Merck Serono’s Commitment to Advance Multiple Sclerosis Care and Research Geneva, Switzerland |
English French German |
|
| 17/06/2010 | Merck Serono Resumes Stimuvax Clinical Program in Lung Cancer Geneva, Switzerland |
English | |
| 10/06/2010 | MERCK SERONO: DATA ON SAFINAMIDE TO BE PRESENTED AT THE 14TH MDS MEETING
Geneva, Switzerland |
English French German |
|
| 08/06/2010 | MERCK SERONO RESUBMITS U.S. APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL MS THERAPY
Geneva, Switzerland |
||
| 05/06/2010 | Cilengitide Study Provides Long-Term Follow-up Data in Glioblastoma Patients Receiving Investigational Drug for More Than
4 Years
Geneva, Switzerland |
English | |
| 01/06/2010 | GLOBAL SURVEY REVEALS ERBITUX IS NOW A STANDARD OF CARE FOR CONFIRMED KRAS WILD-TYPE METASTATIC COLORECTAL CANCER
Geneva, Switzerland |
English | |
| 26/05/2010 | YOUR STORY, YOUR VOICE, YOUR ACHIEVEMENTS, YOUR IDEAS… THIS IS ABOUT LIFE, REAL LIFE, REAL MS
Geneva, Switzerland |
English French |
|
| 25/05/2010 | INTERNATIONAL THYROID AWARENESS WEEK 2010 TO FOCUS ON THYROID DISORDERS AND PREGNANCY
Geneva, Switzerland |
||
| 21/05/2010 | MERCK SERONO PRESENTS FURTHER EVIDENCE OF SUSTAINED INNOVATION IN ONCOLOGY AT ASCO 2010
Geneva, Switzerland |
English | |
| 05/05/2010 | MERCK SERONO AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS Geneva, Switzerland |
||
| 03/05/2010 | MERCK SERONO NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE Geneva, Switzerland |
||
| 22/04/2010 | MERCK SERONO CORPORATE HEADQUARTERS RECEIVES ISO 14001 CERTIFICATION Geneva, Switzerland |
||
| 16/04/2010 | New Data Supporting Cladribine Tablets as a Potential New Therapeutic Option Presented at the62nd AAN Annual Meeting Toronto, Canada / Geneva, Switzerland |
English French German |
|
| 31/03/2010 | Data from Merck Serono’s Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of Neurology Geneva, Switzerland |
English French German |
|
| 29/03/2010 | MERCK SERONO: Erbitux Granted extended Use in Japan for First-Line-Treatment for mCRC-Patients with KRAS wild-type Tumors
Geneva, Switzerland |
English | |
| 23/03/2010 | MERCK SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED
Geneva, Switzerland |
English |
|
| 04/03/2010 |
CARDIFF UNIVERSITY AND MERCK SERONO LAUNCH INTERNATIONAL SURVEY FOR COUPLES TRYING TO CONCEIVE
|
English French German |
|
| 24/01/2010 | ASCO-GI: OVERALL SURVIVAL WITH ERBITUX IS SIGNIFICANTLY IMPROVED IN PATIENTS WITH KRAS WILD-TYPE TUMORS IN CRYSTAL
Geneva, Switzerland |
English | |
| 21/01/2010 | TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF
MEDICINE
Geneva, Switzerland |
||
| 18/01/2010 | LE MAGAZINE BILAN PLACE MERCK SERONO EN TETE DE SON PALMARES 2010 DES MEILLEURS EMPLOYEURS DE SUISSE ROMANDE
Geneva, Switzerland |
French |
| 2009 | |||
| 16/12/2009 | MERCK SERONO ANNOUNCES COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS
Geneva, Switzerland |
English French German |
|
| 10/12/2009 |
MERCK SERONO STARTS STIMUVAX PHASE III STUDY INSPIRE IN ASIAN PATIENTS WITH ADVANCED NSCLC
|
English | |
| 10/12/2009 | MERCK Serono Initiates KAMPER, The First Pan-European Registry for Patients Under Kuvan® therapy
Geneva, Switzerland |
English French German |
|
| 30/11/2009 | MERCK SERONO RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Geneva, Switzerland |
English French German |
|
| 25/11/2009 | MERCK SERONO LAUNCHES NEW WEBSITE ON PHENYLKETONURIA
Geneva, Switzerland |
English French German |
|
| 19/11/2009 | MERCK SERONO TO EXPAND RESEARCH AND DEVELOPMENT PRESENCE IN CHINA
Geneva, Switzerland |
English French German |
|
| 19/11/2009 | MERCK SERONO: CHMP OPINION FOR ERBITUX IN ADVANCED NON-SMALL CELL LUNG CANCER
Geneva, Switzerland |
English | |
| 16/11/2009 |
ERBITUX RECOGNIZED BY ASCO AS A 2009 MAJOR CANCER ADVANCE AS FIRST SCCHN TREATMENT TO IMPROVE SURVIVAL IN 30 YEARS
|
English | |
| 06/11/2009 | PETACC-8 STUDY INVESTIGATING ERBITUX AS ADJUVANT TREATMENT IN COLON CANCER COMPLETES RECRUITMENT
Geneva, Switzerland |
English | |
| 15/10/2009 | MERCK SERONO REÇOIT LE PRIX DE L’INDUSTRIE DE GENEVE
Geneva, Switzerland |
French | |
| 05/10/2009 | MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Geneva, Switzerland |
English French German |
|
| 30/09/2009 | MERCK SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE
UNITED STATES
Geneva, Switzerland |
English French German |
|
| 23/09/2009 | INITIAL COIN STUDY RESULTS PRESENTED AT EUROPEAN ONCOLOGY CONGRESS
Geneva, Switzerland |
English | |
| 16/09/2009 | MERCK SERONO GROWTH HORMONE INJECTION DEVICE EASYPOD® APPROVED IN JAPAN
Geneva, Switzerland |
English French German |
|
| 14/09/2009 | RESULTS OF REBISMART™ USER TRIAL PRESENTED AT 25TH ECTRIMS CONGRESS SHOW BROAD PATIENT ACCEPTANCE OF THE NEW ELECTRONIC DELIVERY
DEVICE FOR RELAPSING MULTIPLE SCLEROSIS TREATMENT REBIF® Geneva, Switzerland |
English French German |
|
| 11/09/2009 | Results from IMPROVE Study Show MRI Benefits of Rebif® Seen Early in Relapsing-Remitting Multiple Sclerosis Treatment and
Sustained Over Time Geneva, Switzerland |
English French German |
|
| 11/09/2009 | NEW DATA FROM CLARITY STUDY ON DISEASE ACTIVITY IN MS PATIENTS WHO RECEIVED CLADRIBINE TABLETS PRESENTED AT 25TH ECTRIMS CONGRESS
Düsseldorf, Germany, and Geneva, Switzerland |
English French German |
|
| 10/08/2009 | EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH
AND CLINICAL TRIALS
Darmstadt, Germany |
English | |
| 04/08/2009 | DATA PRESENTED ON MERCK SERONO’S CILENGITIDE SUPPORT ONGOING CLINICAL EVALUATION IN NSCLC
San Francisco, CA, USA/Darmstadt Germany |
English | |
| 02/08/2009 | Merck Serono Presented New Data On the Combination of Erbitux with Standard First-Line Therapy in Patients with NSCLC
San Francisco, CA, USA / Geneva, Switzerland |
English | |
| 31/07/2009 | MERCK SERONO Has Requested Re-examination of the CHMP Opinion for Erbitux in Non-Small Cell Lung Cancer
Geneva, Switzerland |
English | |
| 24/07/2009 | MERCK SERONO CONSIDERS APPEALING CHMP OPINION ON ERBITUX TREATMENT FOR NON-SMALL CELL LUNG CANCER
Geneva, Switzerland |
English | |
| 23/07/2009 | MERCK SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS
AS MULTIPLE SCLEROSIS THERAPY IN EUROPE Geneva, Switzerland |
English French German |
|
| 16/07/2009 | GONAL-F APPROVED IN JAPAN FOR OVULATION INDUCTION IN INFERTILE WOMEN
Geneva, Switzerland |
English French German |
|
| 15/07/2009 | MERCK SERONO ANNOUNCES LICENSE AGREEMENT WITH BIOWA FOR POTELLIGENT® TECHNOLOGY
Darmstadt, Germany |
English | |
| 01/07/2009 | MERCK SERONO LAUNCHES “GLOBAL FERTILITY ACADEMY” TO PROVIDE EDUCATION AND TRAINING FOR THE TREATMENT OF INFERTILITY
Geneva, Switzerland |
English French German |
|
| 24/06/2009 | MERCK SERONO: LATEST ERBITUX DATA ON METASTATIC COLORECTAL CANCER PRESENTED AT WCGIC UNDERLINE BENEFITS IN PATIENTS WITH KRAS
WILD-TYPE TUMORS
Barcelona, Spain/Darmstadt, Germany |
English | |
| 24/06/2009 | MERCK SERONO LAUNCHES REBISMART™, FIRST ELECTRONIC INJECTION DEVICE FOR DELIVERY OF MULTIPLE SCLEROSIS TREATMENT REBIF®
Geneva, Switzerland |
English French German Italian |
|
| 22/06/2009 | NEW DATA FROM CLARITY STUDY PRESENTED AT 19TH ENS MEETING SHOW RAPID AND SUSTAINED MS RELAPSE REDUCTION FOR CLADRIBINE TABLETS
Geneva, Switzerland |
English French German Italian |
|
| 22/06/2009 | MERCK SERONO INITIATES PHASE III STUDY OF STIMUVAX IN BREAST CANCER Geneva, Switzerland |
English | |
| 03/06/2009 |
FIRST PHASE III CLINICAL TRIAL RESULTS OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE TO BE PRESENTED AT THE MOVEMENT DISORDER
SOCIETY 13TH INTERNATIONAL CONGRESS
|
English French German |
|
| 01/06/2009 | UK’S NICE RECOMMENDS USE OF ERBITUX FOR METASTATIC COLORECTAL CANCER PATIENTS
Geneva, Switzerland |
English | |
| 31/05/2009 | MERCK SERONO AT FOREFRONT OF EXPLORING MARKERS OF RESPONSE IN CONTINUED EFFORT TO PERSONALIZE CANCER CARE
Orlando, FL, USA / Geneva, Switzerland |
English | |
| 31/05/2009 | STUDY SHOWS CILENGITIDE INCREASED OVERALL SURVIVAL IN PATIENTS WITH GLIOBLASTOMA
Orlando, FL, USA / Geneva, Switzerland |
English | |
| 30/05/2009 | FOLLOW-UP FROM STIMUVAX STUDY PROVIDES LONG-TERM SAFETY DATA IN ADVANCED LUNG CANCER PATIENTS RECEIVING TREATMENT FOR UP TO
8.2 YEARS
Orlando, FL, USA / Geneva, Switzerland |
English | |
| 25/05/2009 | MERCK SERONO To Support First International Thyroid Awareness Week
Geneva, Switzerland |
English French German |
|
| 18/05/2009 | MERCK SERONO COMMITTED TO INVESTING IN INNOVATION IN THE FERTILITY AREA
Geneva, Switzerland |
English French German |
|
| 14/05/2009 | MERCK SERONO CHAMPIONS PERSONALIZED CANCER CARE WITH TARGETED THERAPIES
Darmstadt, Germany |
English | |
| 07/05/2009 | RESULTS AT ASCO CONGRESS 2009 HIGHLIGHT MERCK SERONO'S LEADERSHIP IN PERSONALIZING CANCER CARE
Geneva, Switzerland |
English | |
| 07/05/2009 | MERCK SERONO INITIATES SETTLE, THE SECOND PHASE III CLINICAL TRIAL OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE
Geneva, Switzerland |
English French German |
|
| 05/05/2009 | Merck Serono Launches Glucophage Powder in First European Countries
Geneva, Switzerland |
English French German |
|
| 01/05/2009 | STUDY PUBLISHED IN THE LANCET SHOWS ERBITUX SIGNIFICANTLY IMPROVES OVERALL SURVIVAL IN 1ST-LINE NSCLC
Darmstadt, Germany |
English | |
| 30/04/2009 |
Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients with
Multiple Sclerosis |
||
| 21/04/2009 | MERCK SERONO LAUNCHES Kuvan ® in europe
Geneva, Switzerland |
English German French |
|
| 02/04/2009 | MERCK SERONO: PHASE III ERBITUX DATA PUBLISHED IN NEJM CONFIRMENHANCED EFFICACY IN MCRC PATIENTS IN THE 1ST-LINE SETTING
Darmstadt, Germany |
English | |
| 30/03/2009 |
Merck Serono: New Phase III Data for Cladribine Tablets
|
English German French |
|
| 23/03/2009 | MERCK SERONO LAUNCHES STRATEGIC VENTURE CAPITAL FUND Geneva, Switzerland |
English German French |
|
| 18/03/2009 |
Merck Serono and Fast Forward, LLCAnnounce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis |
English German French |
|
| 24/02/2009 | MERCK SERONO AND AMBRX EXPAND COLLABORATION THROUGH ARX424 MULTIPLE SCLEROSIS DRUG DEVELOPMENT ALLIANCE
Geneva, Switzerland |
English German French |
|
| 19/02/2009 |
EUROPEAN MEDICINES AGENCY RECOMMENDS SUSPENSION OF MARKETING AUTHORIZATION FOR RAPTIVA®
|
English German French |
|
| 16/03/2009 |
MERCK SERONO EXPANDS CILENGITIDE DEVELOPMENT PROGRAM
|
English | |
| 03/02/2009 |
Merck Serono’s Safinamide Significantly Improved Motor Function in Patients with Advanced Parkinson’s Disease in a Phase III
Pivotal Trial
|
English German French |
|
| 23/01/2009 | MERCK SERONO LAUNCHES ERBITUX IN 1ST-LINE TREATMENT OF HEAD AND NECK CANCER IN EUROPE
Antwerp, Belgium |
English | |
| 23/01/2009 | MERCK SERONO´S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE
IN TWO-YEAR PHASE III PIVOTAL TRIAL Geneva, Switzerland |
English German French |
|
| 13/01/2009
|
MERCK SERONO AND APITOPE ANNOUNCE LICENSING AGREEMENT ON NOVEL PEPTIDE THERAPEUTICS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
Geneva, Switzerland |
English German French |
